Research on women’s health examines how female biology, hormones and social factors shape disease risk, diagnosis and treatment outcomes across the lifespan.

Cardiovascular disease remains a leading cause of death in women, yet symptoms often differ from classic male patterns, leading to underdiagnosis and undertreatment. Research highlights sex specific risk factors such as pregnancy related complications, polycystic ovary syndrome and premature menopause. These conditions can signal heightened cardiovascular risk many years before traditional markers become apparent, creating opportunities for earlier prevention.

Hormonal changes play a central role. Fluctuations during the menstrual cycle can influence migraine, mood disorders and some autoimmune conditions. Pregnancy research spans preeclampsia, gestational diabetes and the long term impact of pregnancy on maternal metabolic and cardiovascular health. After menopause, declining estrogen is linked to increased risk of osteoporosis, fractures and cardiovascular disease. Studies compare the benefits and risks of hormone therapy, focusing on timing, dosage, route of administration and individual risk profiles.

Cancer research emphasizes breast, ovarian and cervical cancers, with attention to genetic risk, screening strategies and evolving treatments. Advances in imaging, molecular profiling and targeted therapies are improving survival, yet participation of women in clinical trials remains uneven, especially during pregnancy and breastfeeding.

Mental health studies underscore the burden of depression and anxiety, particularly during the perinatal period and around menopause. Integrating mental health into routine gynecologic and primary care is a growing priority.

Across all areas, researchers stress the need for sex specific data, inclusive trial design, attention to diverse populations and a life course approach that connects reproductive events with later health.